2002 CFR Title 42, Volume 1

Title 42--Public Health CHAPTER I--PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 82--METHODS FOR CONDUCTING DOSE RECONSTRUCTION UNDER THE ENERGY EMPLOYEES OCCUPATIONAL ILLNESS COMPENSATION PROGRAM ACT OF 2000
	82.0	Background information on this part.
	82.1	What is the purpose of this part?
	82.2	What are the basics of dose reconstruction?
	82.3	What Are the Requirements for Dose Reconstruction Under EEOICPA?
	82.4	How Will DOL Use the Results of the NIOSH Dose Reconstructions?
	82.5	Definition of terms used in this part.
	82.10	Overview of the dose reconstruction process.
	82.11	For which claims under EEOICPA will NIOSH conduct a dose reconstruction?
	82.12	Will it be possible to conduct dose reconstructions for all claims?
	82.13	What sources of information may be used for dose reconstructions?
	82.14	What types of information could be used in dose reconstructions?
	82.15	How will NIOSH evaluate the completeness and adequacy of individual monitoring data?
	82.16	How will NIOSH add to monitoring data to remedy limitations of individual monitoring and missed dose?
	82.17	What types of information could be used to supplement or substitute for individual monitoring data?
	82.18	How will NIOSH calculate internal dose to the primary cancer site(s)?
	82.19	How will NIOSH address uncertainty about dose levels?
	82.25	When will NIOSH report dose reconstruction results, and to whom?
	82.26	How will NIOSH report dose reconstruction results?
	82.27	How can claimants obtain reviews of their NIOSH dose reconstruction results by NIOSH?
	82.28	Who can review NIOSH dose reconstruction files on individual claimants?
	82.30	How will NIOSH inform the public of any plans to change scientific elements underlying the dose reconstruction process to maintain methods reasonably current with scientific progress?
	82.31	How can the public recommend changes to scientific elements underlying the dose reconstruction process?
	82.32	How will NIOSH make changes in scientific elements underlying the dose reconstruction process, based on scientific progress?
	82.33	How will NIOSH inform the public of changes to the scientific elements underlying the dose reconstruction process?